Evogene share price logo

Evogene Share Price

NASDAQ: EVGN

Small Cap

$0.80

-0.06

(-6.90%)

as on

Evogene Stock Performance

as on April 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.78
    $0.82
    downward going graph

    2.50%

    Downside

    2.50%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.72
    $2.42
    downward going graph

    10.00%

    Downside

    202.50%

    Upside

    downward going graph

Evogene share price movements today

Previous Close
$0.85
Open
$0.82
Volume
511.0K
Day's Low - High
$0.78 - $0.82
52 Week Low - High
$0.72 - $2.42

Evogene Historical Returns

1 Month Return
+ 7.95 %
3 Month Return
-18.66 %
1 Year Return
-14.2 %
3 Year Return
-85.31 %
5 Year Return
-98.05 %

Evogene Stock Fundamentals & Key Indicators

Check Evogene market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.1M

EPS (TTM)

-1.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-13.3M

Revenue (TTM)

3.9M

Profit Margin

-220.22%

Return On Equity TTM

-100.69%

Evogene vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evogene with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Evogene image
Evogene
BUY$8.1M-98.05%NA-220.22%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$44.5B140.06%143.098.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$112.4B101.33%28.8132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.7BNA124.985.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.7B50.01%18.1831.41%

Stock Returns calculator for Evogene Stock including INR - Dollar returns

The Evogene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Evogene investment value today

Current value as on today

₹87,171

Returns

-₹12,829

(-12.83%)

Returns from Evogene Stock

-₹20,000 (-20%)

Dollar Impact

₹7,171 (+7.17%)

Analyst Recommendation on Evogene Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Evogene. Average target price of $1.75

Evogene Share Price Target

Get share price movements and forecasts by analysts on Evogene.

What analysts predicted

54.29%UPSIDE

Target Price

$1.75

Current Price

$0.8

Analyzed by

8 Analysts

Target

$1.75

Evogene target price $1.75, a slight upside of 54.29% compared to current price of $0.8. According to 8 analysts rating.

Evogene Stock’s Investor Sentiment and Interest

Search interest for Evogene Stock has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:64% versus previous 30 day period

Evogene Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
3
0
4
0
1
1
2
0
0
0
Gross Profit
2
0
3
0
0
0
0
0
0
0
Operating Income
-4
-7
-3
-4
-5
-4
-4
-3
-2
-4
EBITDA
-3
-6
-3
-4
-3
0
-1
-2
-1
-4
Interest Expense
0
0
0
0
2
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-7
-3
-4
-6
0
-2
-3
-2
-5
Income Tax Expense
0
0
0
0
0
0
-
0
0
-
Net Income
-3
-6
-3
-5
-7
0
-2
-4
3
-5
Net Profit Margin
-105.76%
-1142.04%
-92.20%
-895.70%
-438.51%
26.51%
-105.85%
-504.75%
1241.67%
-1690.76%

Evogene Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
3
1
0
1
0
1
5
8
3
Gross Profit
0
-1
-1
-2
-2
-2
-1
1
3
0
Operating Income
-21
-21
-21
-22
-26
-31
-29
-26
-21
-13
EBITDA
-17
-18
-18
-15
-23
-27
-26
-23
-15
-12
Interest Expense
0
0
0
0
0
0
0
0
0
1
Depreciation
-
2
2
2
2
2
2
2
2
1
Income Before Tax
-19
-20
-20
-19
-26
-30
-29
-25
-18
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-19
-20
-20
-18
-23
-27
-26
-23
-16
-8
Net Profit Margin
-299.57%
-616.33%
-1188.21%
-2405.31%
-2247.50%
-2988.49%
-1590.33%
-423.39%
-193.69%
-220.22%

Evogene Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-3
-5
-8
0
-2
-3
-4
-5
Operating Cash Flow
-5
-4
-5
-4
-5
-5
-7
-3
-3
Investing Cash Flow
0
-4
3
2
8
-2
0
11
10
Financing Cash Flow
0
0
0
4
0
0
4
-10
0
Change in Cash
-6
-8
-2
1
3
-7
0
-2
7

Evogene Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-20
-19
-26
-30
-29
-25
-18
-14
Operating Cash Flow
-15
-15
-17
-19
-24
-23
-21
-19
-13
Investing Cash Flow
15
17
37
9
-20
13
-4
9
17
Financing Cash Flow
0
0
9
20
30
9
18
4
-6
Change in Cash
0
2
28
11
-13
-3
-8
-5
-2

Global Institutional Holdings in Evogene

Funds
Holdings
Royal Bank of Canada
0%
JPMorgan Chase & Co
0%
XTX Topco Ltd
0.26%
TWO SIGMA SECURITIES, LLC
0.13%
Tidemark LLC
0%
See all

Insights on Evogene

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 312.0K → 314.0K (in $), with an average increase of 0.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 61.9% return, outperforming this stock by 147.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 42.1% return, outperforming this stock by 54.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, EVGN stock has moved down by -85.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 3.87M → -5.30M (in $), with an average decrease of 237.0% per quarter

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
OrganisationEvogene
Headquarters13 Gad Feinstein Street, Rehovot, Israel, 7638517
IndustryBiotechnology
CEOMr. Ofer Haviv CPA
E-voting on sharesClick here to vote

Key Management of Evogene

Name

Title

Mr. Yoash Zohar

Chief Executive Officer of Casterra Ag Ltd.

Dr. Dan Jacob Gelvan Ph.D.

Chief Executive Officer of Ag Plenus Ltd.

Ms. Polina Ravzin

Chief Financial Officer

Dr. Ilia Zhidkov

Chief Technology Officer

Ms. Liat Foigel Wejgman

Vice President of Human Resources

Dr. Gabi Tarcic Ph.D.

Chief Development Officer

Mr. Ofer Haviv CPA

CEO, President & Director

FAQs

What is Evogene share price today?

Evogene share price today is $0.8 as on at the close of the market. Evogene share today touched a day high of $0.82 and a low of $0.78.

What is the 52 week high and 52 week low for Evogene share?

Evogene share touched a 52 week high of $2.42 on and a 52 week low of $0.72 on . Evogene stock price today i.e. is closed at $0.8,which is 66.94% down from its 52 week high and 11.11% up from its 52 week low.

What is Evogene's market capitalisation today?

Evogene market capitalisation is $0.00T as on .

How to invest in Evogene Stock (EVGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evogene on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evogene Shares that will get you 1.8750 shares as per Evogene share price of $0.8 per share as on April 17, 2026 at 1:29 am IST.

What is the minimum amount required to buy Evogene Stock (EVGN) from India?

Indian investors can start investing in Evogene (EVGN) shares with as little as ₹93.289 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.89 in Evogene stock (as per the Rupee-Dollar exchange rate as on ). Based on Evogene share’s latest price of $0.8 as on April 17, 2026 at 1:29 am IST, you will get 12.5000 shares of Evogene. Learn more about fractional shares .

What are the returns that Evogene has given to Indian investors in the last 5 years?

Evogene stock has given -98.05% share price returns and 25.08% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?